HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heinrich Iro Selected Research

Pleomorphic Adenoma

1/2022Histopathology of Parotid Pleomorphic Adenomas: A "Pleomorphic Approach" to a Demanding Lesion.
12/2021Pleomorphic Adenoma of the Parotid Gland and the Parapharyngeal Space: Two Diametrically Opposing Surgical Philosophies for the Same Histopathologic Entity?
1/2021Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures.
9/2019Parotid pleomorphic adenomas: Factors influencing surgical techniques, morbidity, and long-term outcome relative to the new ESGS classification in a retrospective study.
12/2017Long-term oncologic and functional outcome in pleomorphic adenomas of the submandibular gland.
6/2013Follow-up of parotid pleomorphic adenomas treated by extracapsular dissection.
5/2009Salivary leptin as a candidate diagnostic marker in salivary gland tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heinrich Iro Research Topics

Disease

60Neoplasms (Cancer)
05/2022 - 07/2003
19Carcinoma (Carcinomatosis)
05/2022 - 05/2009
16Squamous Cell Carcinoma of Head and Neck
08/2022 - 01/2013
14Head and Neck Neoplasms (Head and Neck Cancer)
04/2022 - 12/2004
12Salivary Gland Calculi (Sialolithiasis)
01/2022 - 12/2009
9Neoplasm Metastasis (Metastasis)
11/2022 - 12/2005
8Shock
01/2022 - 05/2004
7Pathologic Constriction (Stenosis)
06/2022 - 09/2009
7Margins of Excision
05/2022 - 07/2010
7Pleomorphic Adenoma
01/2022 - 05/2009
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2021 - 07/2007
5Laryngeal Neoplasms (Laryngeal Cancer)
01/2022 - 07/2010
4Paraganglioma (Paragangliomas)
01/2022 - 07/2012
4Carcinogenesis
08/2016 - 06/2014
3Abscess
11/2022 - 10/2020
3Salivary Gland Neoplasms (Salivary Gland Cancer)
05/2022 - 05/2013
3Oropharyngeal Neoplasms
04/2022 - 12/2005
3Residual Neoplasm
01/2022 - 07/2005
3Deglutition Disorders (Dysphagia)
10/2021 - 10/2020
3Acinar Cell Carcinoma
02/2021 - 01/2019
3Infections
08/2017 - 03/2010
3Acoustic Neuroma (Acoustic Neurinoma)
04/2017 - 01/2017
3Sialadenitis
01/2014 - 07/2009
2Lymphatic Metastasis
05/2022 - 02/2021
2Disease Progression
05/2022 - 07/2005
2Postoperative Pain
01/2022 - 01/2021
2Tonsillitis
12/2021 - 10/2020
2Salivary Gland Diseases (Salivary Gland Disease)
10/2021 - 07/2009
2Pain (Aches)
01/2021 - 02/2014
2Nasal Polyps (Nasal Polyp)
01/2020 - 10/2019
2Rhinosinusitis
01/2020 - 10/2019
2Wounds and Injuries (Trauma)
12/2017 - 05/2009
2Neurofibromatoses (Neurofibromatosis)
04/2017 - 01/2017
2Lymphoma (Lymphomas)
01/2017 - 06/2015
2Melanoma (Melanoma, Malignant)
01/2017 - 06/2015
2Obstructive Sleep Apnea
12/2016 - 05/2016
2Otosclerosis
12/2013 - 01/2010
2Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
12/2005 - 05/2004
1Peritonsillar Abscess
11/2022
1Anaplastic Thyroid Carcinoma
11/2022
1Hemorrhage
11/2022
1Suppuration
11/2022
1Seroma
08/2022
1Bruxism
06/2022
1Multiple Myeloma
05/2022

Drug/Important Bio-Agent (IBA)

7Cisplatin (Platino)FDA LinkGeneric
04/2021 - 12/2004
6Docetaxel (Taxotere)FDA Link
04/2021 - 01/2011
5Capsules (Microcapsules)IBA
01/2022 - 06/2018
4Biological ProductsIBA
01/2022 - 01/2017
4Pharmaceutical PreparationsIBA
10/2020 - 01/2005
4Biomarkers (Surrogate Marker)IBA
10/2019 - 01/2014
4Proteins (Proteins, Gene)FDA Link
09/2014 - 12/2005
3Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 07/2012
3PlatinumIBA
04/2022 - 04/2015
3Immune Checkpoint InhibitorsIBA
04/2021 - 02/2021
3Carboplatin (JM8)FDA LinkGeneric
01/2020 - 01/2011
2Opioid Analgesics (Opioids)IBA
01/2022 - 01/2021
2tremelimumabIBA
04/2021 - 10/2020
2durvalumabIBA
04/2021 - 10/2020
2B7-H1 AntigenIBA
02/2021 - 11/2017
2Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 12/2004
2Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2019
2ParaffinIBA
11/2017 - 07/2007
2Messenger RNA (mRNA)IBA
08/2017 - 01/2013
2Bevacizumab (Avastin)FDA Link
04/2017 - 01/2017
2Phenobarbital (Luminal)FDA Link
01/2017 - 09/2009
2N 30IBA
08/2016 - 01/2011
2MethyltransferasesIBA
09/2014 - 01/2013
2ElementsIBA
01/2014 - 05/2012
2AntibodiesIBA
03/2013 - 07/2012
1A-factor (Streptomyces)IBA
05/2022
1Tyrosine Kinase InhibitorsIBA
04/2022
1selpercatinibIBA
04/2022
1lenvatinibIBA
04/2022
1LigandsIBA
04/2022
1Sorafenib (BAY 43-9006)FDA Link
04/2022

Therapy/Procedure

43Therapeutics
11/2022 - 05/2004
20Radiotherapy
06/2022 - 12/2004
13Chemoradiotherapy
04/2022 - 12/2004
13Lithotripsy (Extracorporeal Shockwave Lithotripsy)
01/2022 - 05/2004
10Lasers (Laser)
08/2022 - 07/2010
8Neck Dissection (Radical Neck Dissection)
05/2022 - 06/2012
8Drug Therapy (Chemotherapy)
05/2022 - 04/2015
6Induction Chemotherapy
04/2021 - 01/2011
6Aftercare (After-Treatment)
01/2021 - 01/2008
4Laryngectomy
01/2022 - 08/2010
3Tonsillectomy
11/2022 - 07/2012
3Cochlear Implantation
08/2022 - 01/2021
3Immunotherapy
01/2022 - 01/2021
3Punctures
12/2021 - 02/2005
3Conservative Treatment
01/2020 - 01/2005
3Reoperation
01/2019 - 06/2015
2Radioimmunotherapy
01/2022 - 10/2020
2Adjuvant Radiotherapy
01/2022 - 12/2013
2Free Tissue Flaps
04/2021 - 09/2012
2Combined Modality Therapy
01/2019 - 10/2018
2Stents
05/2016 - 01/2013
2Adjuvant Chemoradiotherapy
01/2016 - 11/2012
2Laser Therapy (Surgery, Laser)
07/2010 - 09/2009
1Surgical Hemostasis
11/2022